Clinical Trial Update: Cannabinoids as a Treatment for Insomnia in Major Depression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cannabinoids for insomnia in adults with major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Major Depressive Disorder

Drugs mentioned

• Cannabinoids (cannabinoids)

Snippet

Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Insomnia, Depressive Disorder, Major | Phase 2 | Status: COMPLETED